Aptus Pharma Limited (BOM:544529)
221.95
+3.95 (1.81%)
At close: Jan 16, 2026
Aptus Pharma Revenue
Aptus Pharma had revenue of 71.89M INR in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 291.80M. In the fiscal year ending March 31, 2025, Aptus Pharma had annual revenue of 245.58M with 37.52% growth.
Revenue (ttm)
291.80M
Revenue Growth
+37.52%
P/S Ratio
5.65
Revenue / Employee
4.17M
Employees
70
Market Cap
1.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 245.58M | 67.01M | 37.52% |
| Mar 31, 2024 | 178.57M | 39.60M | 28.49% |
| Mar 31, 2023 | 138.97M | 33.91M | 32.27% |
| Mar 31, 2022 | 105.07M | 54.11M | 106.18% |
| Mar 31, 2021 | 50.96M | 2.27M | 4.67% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 7.48B |
| Chemkart India | 1.93B |
| Rama Vision | 1.34B |
| Checkpoint Trends | 1.21B |
| Khemani Distributors & Marketing | 1.09B |
| VijayPD Ceutical | 1.07B |
| Vaidya Sane Ayurved Laboratories | 979.90M |
| Novelix Pharmaceuticals | 849.03M |